Cell Line Development: Faster Path To A Stable Master Cell Bank

Cell line development (CLD) is a foundational step in biologics manufacturing, enabling the production of complex therapeutic proteins using engineered living cells. The process begins by introducing a gene of interest into host cells—commonly Chinese Hamster Ovary (CHO) cells—and selecting clones that demonstrate high productivity and stability.

A critical milestone in this workflow is the creation of the Master Cell Bank (MCB), which consists of a well-characterized, genetically stable population derived from a single clone. This bank is cryopreserved and serves as the primary, reproducible source for all future manufacturing, ensuring product consistency and regulatory compliance.

Throughout development, clones undergo extensive screening, monoclonality verification, and quality testing to confirm identity, purity, and long-term performance. By minimizing variability and contamination risk, CLD and MCB establishment provide a robust foundation for scalable, reliable production of biologics across the product lifecycle.